Lv41
414 积分 2024-11-27 加入
MRPL21 promotes HCC proliferation through TP53 mutation-induced apoptotic resistance
6小时前
待确认
Ethnic diversity in the genetics of venous thromboembolism
14天前
已完结
Thrombophilia, risk factors and prevention
15天前
已完结
Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2
21天前
已完结
Venous Thromboembolism in Patients Diagnosed With Lung Cancer
21天前
已完结
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer
25天前
已完结
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer
25天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
25天前
已完结
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer
25天前
已完结
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study
25天前
已完结
皖公网安备34019202002308
